Australian-New Zealand Clinical Trial: D-Cycloserine Augmentation of Optimised Accelerated TMS for Treatment Resistant Depression (END-Depression study)

Australia, Oct. 28 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘D-Cycloserine Augmentation of Optimised Accelerated TMS for Treatment Resistant Depression (END-Depression study)’. The following are the other relevant details related to the trial:

Trial ID: 392402

Submit Date: 10/2/26 8:53

Study Type: Interventional

Intervention: The intervention comprises a computational pipeline developed by the researchers to individually tailor the transcranial magnetic stimulation (TMS) target based on each participant's brain connectivity, as determined by analysis of their functional MRI scan. Device: Intermittent Theta Burst Stimulation (iTBS) iTBS will be administered with a ma...